DTU Logo
About the DTU | News | Staff | Alumni | Contact/Find us | Job opportunities

Professor Rury Holman



Conference Abstracts (17 of 93)


Search Conference Abstracts :

2007

2nd International Congress on Prediabetes and the Metabolic Syndrome, Barcelona (Oral)
Does metformin prevent cardiovascular events?
Holman RR
Diabetes & Vascular Disease Research 2007;4:Suppl 1:S26
[Abstract]
2nd International Congress on Prediabetes and the Metabolic Syndrome, Barcelona (Oral)
Abdominal obesity, metabolic syndrome and global cardiometabolic risk
Holman RR
Diabetes & Vascular Disease Research 2007;4:Suppl 1:S37
[Abstract]
2nd International Congress on Prediabetes and the Metabolic Syndrome, Barcelona (Oral)
A new era in the secondary prevention of CVD in prediabetes - the Acarbose Cardiovascular Evaluation (ACE) trial
Holman RR
Diabetes & Vascular Disease Research 2007;4:Suppl 1:S40
[Abstract]
2nd International Congress on Prediabetes and the Metabolic Syndrome, Barcelona (Oral)
The expanding evidence base - what have we added to our understanding of diabetes disease modification?
Holman RR
Diabetes & Vascular Disease Research 2007;4:Suppl 1:S43-S44
[Abstract]
2nd International Congress on Prediabetes and the Metabolic Syndrome, Barcelona (Poster)
Acarbose Cardiovascular Evaluation (ACE) Trial in prediabetic subjects
Holman RR, Pan CY
Diabetes & Vascular Disease Research 2007;4:Suppl 1:S128
[Abstract]
67th Scientific Session of the American Diabetes Association, Chicago (Poster)
The Oxford Risk Engine: A Cardiovascular Risk Calculator for Individuals with or without Type 2 diabetes
Coleman RL, Stevens RJ, Holman RR
Diabetes 2007;56:Suppl 1:A170
[Abstract]
The Diabetes UK Annual Professional Conference, Glasgow (Poster)
Estimating cardiovascular disease risk for individuals with Type 2 diabetes: the new UKPDS Risk Engine
Coleman RL, Stevens RJ, Holman RR
Diabetic Medicine 2007;24:Suppl 1:56
[Abstract]
67th Scientific Session of the American Diabetes Association, Chicago (Publication only)
Life-expectancy in Individuals with Type 2 Diabetes: Implications for Annuities.
Price HC, Cull CA, Clarke PM, Gray AM and Holman RR
Diabetes 2007;56:Suppl 1:A596
[Abstract]
The Diabetes UK Annual Professional Conference, Glasgow (Poster)
Framingham Equations Underestimate Cardiovascular Risk Compared with the UKPDS Risk Engine in People with Type 2 Diabetes.
Price HC, Cull CA, Coleman RL, Stevens RJ and Holman RR
Diabetic Medicine 2007;24:suppl 1:55
[Abstract]
28th Annual Conference of the International Society for Clinical Biostatistics, Alexandroupolis (Oral)
Modelling Continuous Glucose Monitoring Data: A Statistical Challenge
Paul SK, Holman RR
ISCB Abstracts 2007;117
[Abstract]
43rd Annual Meeting of the European Association for the Study of Diabetes, Amsterdam (Poster)
Are measures of adiposity associated independently with incident cardiovascular disease in individuals with newly diagnosed type 2 diabetes?
Coleman RL, Holman RR
Diabetologia 2007;50:Suppl 1:S502
[Abstract]
43rd Annual Meeting of the European Association for the Study of Diabetes, Amsterdam (Oral)
Increased incidence of fractures in women who received rosiglitazone in ADOPT (A Diabetes Outcome Progression Trial)
Kahn SE, Zinman B, Lachin JM, Haffner SM, Herman WH, Holman RR, Kravitz BG, Yu D, Heise MA, Aftring RP, Viberti G; Diabetes Outcome Progression Trial (ADOPT) Study Group
Diabetologia 2007; (Accepted)
[Abstract]
43rd Annual Meeting of the European Association for the Study of Diabetes, Amsterdam (Oral)
Greater reductions in C-reactive protein with rosiglitazone than with glyburide or metformin despite greater weight gain
Haffner SM, Kahn SE, Zinman B, Holman R, Viberti GF, Herman WH, Lachin JM, Kravitz BG, Heise MA
Diabetologia 2007; (Accepted)
[Abstract]
43rd Annual Meeting of the European Association for the Study of Diabetes, Amsterdam (Oral)
The distribution of macular hard exudates is related to future visual acuity in subjects with type 2 diabetes
Stratton IM, Scanlon PH, Holman RR, Stirling RJ, Lipinsk HL, Aldington SJ
Diabetologia 2007; (Accepted)
[Abstract]
43rd Annual Meeting of the European Association for the Study of Diabetes, Amsterdam (Poster)
Prevalence of glucokinase (GCK) mutations in people with elevated fasting glucose levels: implications for clinical trials
Gloyn AL, van de Bunt M, Stratton I, Tucker L, Lonie L, Ellard S, Holman RR
Diabetologia 2007; (Accepted)
[Abstract]
43rd Annual Meeting of the European Association for the Study of Diabetes, Amsterdam (Poster)
Determinants of monotherapy failure in ADOPT (A Diabetes Outcome Progression Trial)
Holman RR, Kahn SE, S. Haffner M, Zinman B, Viberti GF, Herman WH, Lachin JM, Kravitz BG, Heise MA
Diabetologia 2007; (Accepted)
[Abstract]
43rd Annual Meeting of the European Association for the Study of Diabetes, Amsterdam (Poster)
ADOPT: The effectiveness of metformin versus glyburide in type 2 diabetes
Herman WH, Haffner SM, Kahn SE, Zinman B, Holman RR, Viberti GF, Lachin JM, Kravitz BG, Heise MA
Diabetologia 2007; (Accepted)
[Abstract]